Mesa Biotech Pandemic Pushes Handheld qPCR Devices Closer to Commercialization Premium Miniaturized sample-to-answer devices in development hint at an evolving molecular diagnostics landscape but launch timelines for these platforms remain unclear. FDA Posts Info on Impact of SARS-CoV-2 Mutations on Test Effectiveness The FDA identified molecular tests from Mesa Biotech, Applied DNA Sciences, Thermo Fisher Scientific, and Cepheid that could be affected by certain mutations. Thermo Fisher Scientific to Acquire Mesa Biotech for Up to $550M The firm sells a rapid, point-of-care, PCR platform for infectious disease diagnostics, including SARS-CoV-2, influenza, respiratory syncytial virus, and strep A. FDA Issues Alert About Potential False Negative Test Results From SARS-CoV-2 Mutations The agency identified three tests potentially impacted by known mutations, and said it will continue to monitor authorized assays. Mesa Biotech Receives 510(k) Clearance, CLIA Waiver for Strep A Molecular Point-of-Care Test The firm said its test fits in the palm of a hand and delivers results in 30 minutes by detecting bacterial nucleic acid in throat, nasal, or nasopharyngeal swabs. Nov 6, 2020 Mesa Biotech Awarded $13M in BARDA Funding for Coronavirus, Flu Combo Test Jul 31, 2020 NIH Awards $249M to Seven Firms for Rapid Acceleration of COVID-19 Diagnostics Apr 24, 2020 People in the News: Megan Bailey, Maureen Cronin, Ronald Park, Ingo Chakravarty, More Apr 1, 2020 Despite Potential, Experts Debate Whether Decentralized MDx for Coronavirus Can Flatten Curve Mar 24, 2020 Mesa Biotech COVID-19 Test Receives FDA Emergency Use Authorization Mar 18, 2020 Mesa Biotech Point-of-Care Coronavirus Test Development Receives $561,330 From BARDA Mar 12, 2020 Mesa Biotech Prepping Handheld Coronavirus Molecular Diagnostic System for EUA Premium Aug 5, 2019 Molecular Testing for Flu Catching up, But Still Lags Far Behind Use of Rapid Immunoassays Premium Nov 27, 2018 Mesa Biotech Respiratory Tract Infection Test Gets FDA Clearance, CLIA Waiver Nov 13, 2018 Mesa Biotech RSV Test Wins CE Mark Breaking News IndyGeneUS AI Acquires Genetic Cryptocurrency Creator EncrypGen Analysis Estimates Psychiatric Disorder Risk from Specific Copy Number Variants in Danish Cohort Proteomic Profiling With Two Platforms Provides Complementary Gene, Protein, Phenotype Links Centogene Reports 17 Percent Drop in Q3 Revenues, Closing Down COVID Testing Business StageZero Raising C$4.2M in Private Placement of Stocks, Warrants NGeneBio Gets CE-IVD Mark for HLA Typing Assay The Scan Comfort of Home The Guardian reports that AstraZeneca is to run more clinical trials from people's homes with the aim of increasing participant diversity. Keep Under Control Genetic technologies are among the tools suggested to manage invasive species and feral animals in Australia, Newsweek says. Just Make It The New York Times writes that there is increased interest in applying gene synthesis to even more applications. Nucleic Acids Research Papers on OncoDB, mBodyMap, Genomicus In Nucleic Acids Research this week: database to analyze large cancer datasets, human body microbe database, and more.